Informational Meetings for Planning and Coordinating Treatment

Age

• The child ≥ 7 years of age does not provide assent

Other

• The parent has neurological/cognitive impairments likely to interfere with study participation;
• Parent refuses to be audio recorded during sessions.

• Child 1 month to \< 18 years
• Child newly diagnosed, i.e., within 16 weeks (112 days) from time of diagnosis of cancer not including the day of diagnosis, OR
• Child with relapsed cancer, defined as within 16 weeks (112 days) of first-time relapse/evidence of progression of disease as noted by scan or biopsy after previous diagnosis of cancer.
• Child provide assent if age ≥ 7 years
• Poor prognosis, i.e., approximate \< 25 % estimated overall survival or at the discretion of the attending AND/OR:
• Falls into one of the following diagnosis categories, including but not limited to:
  • Atypical teratoid rhabdoid tumor
  • Glioblastoma multiforme
  • Diffuse intrinsic brainstem glioma
  • Embryonal tumors with multilayered rosettes
  • Other high-grade glioma
  • Gliomatosis cerebri
  • Metastatic osteosarcoma
  • Metastatic Ewing sarcoma
  • Metastatic rhabdomyosarcoma
  • Metastatic desmoplastic small round cell tumor (DSRCT)
  • Other metastatic sarcoma/carcinoma-at discretion of attending
  • Metastatic unknown primary- or rare pathology- at discretion of attending
• Parent(s) legal decision-maker(s) for child
• Parent(s) ≥18 years of age
• Parent (s) Informed of child's cancer diagnosis
• Parent(s) Able to read, speak and understand English
• Must be willing to be audio recorded during all study sessions.